Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 24, 2010

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Synchronous Metastasized Breast CancerCirculating Tumor Cells
Interventions
PROCEDURE

Surgery

lumpectomy or mastectomy with or without radiotherapy. Sentinel biopsy followed by axillary dissection (level I-II)

PROCEDURE

Surgery on Demand

if necessary local therapy on demand

Trial Locations (14)

1090

Medical University of Vienna-General Hospital Vienna, Vienna

Medical University of Vienna, Vienna

4010

Ordensklinikum Linz GmbH - BHS Linz, Coop. Study Group, Linz

Ordensklinikum Linz GmbH - Elisabethinen Linz, Linz

4020

General Hospital Linz, Linz

4600

Klinikum Wels-Grieskirchen GmbH, Wels

5020

Paracelsus Medical University Salzburg-Oncology, Coop. Group, Salzburg

6020

Medical University of Innsbruck, Innsbruck

6807

State Hospital Feldkirch, Feldkirch

7350

Hospital Oberpullendorf, Oberpullendorf

7540

Hospital Guessing, Güssing

8036

Gynaegological Medical University Graz, Graz

Medical University Graz, Oncology, Graz

9300

Ordination Dr. Wette, Saint Veit A. D. Glan

All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Amgen

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

Wyeth-Lederle Pharma GmbH

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Fond of the Viennese Mayor

OTHER

lead

Austrian Breast & Colorectal Cancer Study Group

NETWORK